Feb 25, 2026 04:05PM
Aug 6, 2025 04:05PM
Apr 29, 2025 08:45AM
Mar 15, 2025 04:00PM
May 10, 2023 04:05PM
May 2, 2023 07:00AM
May 2, 2023 07:00AM ADMA Biologics Announces Amendment to Credit Agreement
May 2, 2023 07:00AM
Jan 19, 2022 07:04AM
Jan 19, 2022 07:00AM
Jan 19, 2022 07:00AM
Jan 18, 2022 07:03AM
Jan 18, 2022 07:00AM
Jan 18, 2022 07:00AM ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC
Dec 21, 2021 07:10AM
Dec 21, 2021 07:00AM
Dec 21, 2021 07:00AM
Sep 8, 2021 09:20AM
Apr 28, 2021 09:30AM
Dec 16, 2020 04:16PM
Dec 16, 2020 04:15PM ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
Dec 16, 2020 04:15PM
Sep 3, 2020 08:56AM
Aug 24, 2020 09:31AM
Feb 7, 2020 09:09AM
Feb 6, 2020 06:01PM
Nov 6, 2019 05:02PM
Nov 6, 2019 05:02PM ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
Oct 17, 2019 07:29AM
Oct 17, 2019 07:29AM
Sep 23, 2019 07:08AM
Sep 23, 2019 07:08AM
Aug 22, 2019 07:49AM
Aug 22, 2019 07:48AM
Aug 22, 2019 07:48AM ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
Aug 8, 2019 07:08AM
Aug 8, 2019 07:08AM
Jul 8, 2019 08:22AM
Jul 8, 2019 08:22AM
Jul 8, 2019 08:22AM
May 29, 2019 07:11AM
May 29, 2019 07:11AM ADMA Biologics to Present at Upcoming Investor Conferences
May 16, 2019 08:00AM
May 10, 2019 06:59AM
May 10, 2019 06:58AM
May 10, 2019 06:58AM
May 8, 2019 04:18PM
May 8, 2019 04:18PM
May 3, 2019 07:19AM ADMA Biologics (ADMA) Reports Decision to Draw-Down $27.5M in Capital from Existing Perceptive Advisors Credit Agreement
May 3, 2019 07:18AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All